Viewing StudyNCT00257348



Ignite Creation Date: 2024-05-05 @ 12:09 PM
Last Modification Date: 2024-10-26 @ 9:21 AM
Study NCT ID: NCT00257348
Status: COMPLETED
Last Update Posted: 2013-02-08
First Post: 2005-11-21

Brief Title: Capecitabine and Docetaxel in AdvancedRecurrent Cervical Cancer
Sponsor: University of California Irvine
Organization: University of California Irvine

Organization Data

Organization: University of California Irvine
Class: OTHER
Study ID: UCI 03-04
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: University of California Irvine
Lead Sponsor Class: OTHER
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators

Name Class
Aventis Pharmaceuticals INDUSTRY